• Economy
  • Politics
  • Society
  • Securities
  • Real estate
  • Culture
  • Entertainment
  • Sports
  • Opinion
Economy Corporation Pharma & Bio
Society Politics IT·Science
Securities Real Estate Global
Opinion Entertainment Sports Culture
Video Auto in Golf in
PHARM EDAILY Market in TheBeLT
IT·Science
Science

Contech Wins Additional Contract for Ground Station Construction Project from a Kazakhstani Research Institute

#Contex secured an additional contract for a satellite ground station construction project from a Kazakhstani government-funded research institute at the “International Space Summit (ISS) 2026” held o…
  • 2026-06-17 08:46:30
  • Kang Min-koo
Technology

SK Bioscience Forecasts Earnings Rebound, Led by Its Two Mainstays: CDMO and Next-Generation Pneumonia Vaccine

#SK Bioscience is aiming for a turnaround in its earnings by focusing on its contract development and manufacturing (CDMO) business and its 21-valent pneumococcal vaccine candidate, “GBP410.” As the c…
  • 2026-06-17 08:41:02
  • Hong Ju-yeon
Technology

Flitto to Supply AI Translation and Interpretation Solution to Shinhan Bank Vietnam… Supports 38 Languages

#Flitto, an artificial intelligence (AI) data and solutions company, has supplied its AI-based translation and interpretation solution to a branch of Shinhan Vietnam Bank in Vietnam. Flitto Supplie…
  • 2026-06-17 08:39:00
  • Lee So-Hyun
Technology

Genome & Company’s ‘Business Transformation’: ADC Trio as Future Growth Drivers

#Genome & Company is transforming from a microbiome company into a firm specializing in antibody-drug conjugates (ADCs). As recently as two years ago, the company was strongly associated with the deve…
  • 2026-06-17 08:31:02
  • Hong Ju-yeon
Technology

G2G Bio Makes a Bold Move into the Next-Generation Obesity Treatment Market with Its Long-Acting Platform

#G2G Bio, a drug delivery system (DDS) platform company, is accelerating its push into the next-generation obesity treatment market by leveraging its long-acting drug delivery technology. G2G Bio is s…
  • 2026-06-17 08:21:04
  • Minji Son
Technology

Partnership with a Leading U.S. AI Healthcare Company Imminent... Signaling a Quantum Leap in Earnings [In-Depth Look at Medipixel ③]

For medical artificial intelligence (AI) companies, the domestic market is viewed as a valuable testing ground and home turf for validating their technological capabilities. However, to achieve sustai…
  • 2026-06-17 08:21:03
  • Kim Seung-kwon
Technology

The “Lock-in Effect” Created by a “7-Second” Innovation… Non-Insured Services Take Flight [In-Depth Look at Medipixel ②]

The cardiovascular catheterization lab, where every second counts in emergency situations, is considered a veritable silent battlefield. In this high-pressure environment, where a patient’s life hinge…
  • 2026-06-17 08:21:02
  • Kim Seung-kwon
Technology

CEO Song Gyo-seok: "We pivoted from lung cancer to cardiovascular AI diagnostics... and crossed the 'Valley of Death'" [In-Depth Look at Medipixel ①]

In the spring of 2016, the match between Lee Sedol, a 9-dan professional Go player, and the artificial intelligence (AI) program AlphaGo sent shockwaves around the world. While for some it was merely …
  • 2026-06-17 08:21:01
  • Kim Seung-kwon
Technology

'Insurance for Baldness?' Policy Hopes Drive 30% Surge in JW Pharma [K-bio Pulse]

The government’s plan to review health insurance coverage for hair-loss treatments triggered sharp price movements in Korea’s pharmaceutical and biotech sectors on June 15. Hair-loss drug manufacturer…
  • 2026-06-17 08:01:04
  • Kim Seung-kwon
Technology

“Hair Loss Stock Day”… JW New Drug, Hyundai Pharmaceutical, and Samik Pharmaceutical Rise on Policy Momentum [Bio Spotlight]

On the 15th, the domestic pharmaceutical and biotech sector was in turmoil following news that the government is considering covering hair loss treatments under the national health insurance system. W…
  • 2026-06-17 08:01:04
  • Kim Seung-kwon
prev 21 22 23 24 25 26 27 28 29 30 next

PHARM EDAILY

Shorts

EDAILY
  • 92, Tongil-ro, Jung-gu, Seoul, Korea
  • +82 2 3772 0114
  • webmaster@edaily.co.kr

※ This article has been translated using AI technology for the convenience of readers.

EDAILY provides this translation on an “as is” basis and makes no warranties, express or implied, regarding its accuracy, reliability, completeness, merchantability, or fitness for a particular purpose.
Due to the limitations of machine translation, the translated content may differ from the original Korean article. In the event of any discrepancy, the original Korean version shall prevail.
EDAILY shall not be liable for any loss or damage arising from the use of, or reliance on, the translated content.

© 2026 Copyrights by edaily. All Rights Reserved.
Korea
English